secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K/A
Filed at:   2022-06-09T23:59:59+00:00
Accession:  0001213900-22-031976
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

ABVC BioPharma appoints Hsin-Hui Miao to board after director's passing
-----------------------------------------------------------------------

- Director Dr. Shin-Yu Miao passed away; vacancy filled by his sister Hsin-Hui Miao.
- Ms. Miao appointed on June 4, 2022, effective immediately, serving until next annual meeting.
- She will join Audit, Corporate Governance & Nomination, and Compensation committees.
- Ms. Miao receives $3,500 monthly compensation, same as other directors.
- No related-party transactions above $120,000 or 1% of assets in last two years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390022031976/0001213900-22-031976-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390022031976/ea161330-8ka1_abvc.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-031976

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer